Brokerages Set Axsome Therapeutics, Inc. (NASDAQ:AXSM) Target Price at $172.33
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) has received a consensus rating of “Buy” from the sixteen analysts that are presently covering the stock, Marketbeat reports. Fifteen research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12-month target price among […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) has received a consensus rating of “Buy” from the sixteen analysts that are presently covering the stock, Marketbeat reports. Fifteen research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12-month target price among […]
